Ledger.Open graph →
SEC Form D · Amendment · filed November 3, 2021

OncoNano Medicine, Inc

Offering
$68.4M
Sold
$68.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Southlake, TX
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Alvaro Guillem · Southlake, TXDirectorMartin Driscoll · Southlake, TXExec · DirectorYumin Qiu · Southlake, TXDirectorMatthew Head · Southlake, TXExecJohn Dyett · Southlake, TXDirectorBronwyn Wright · Dublin 2, IrelandExecNoel Ford · Dublin 2, IrelandDirectorCristobal Perdomo Riveros · Ciudad de Mexico, O5DirectorAaron I. Payas · Queensway, J1Exec · DirectorTara Iii LLC · Santa Monica, CADirectorEric W. Chan · San Francisco, CADirectorPaul J. Hopper · New York, NYExecJeffrey R. Bartfeld · San Francisco, CADirectorScott Conway · Incline Village, NVExec · DirectorSheldon Inwentash · Toronto, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗